Covered recipient · General Payments record
SHARDA RAMSAROOP
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2019–2024
$2,357.81
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $228.05 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $63.86 | 3 |
| Acerta Pharma LLC | $51.89 | 3 |
| GlaxoSmithKline, LLC. | $40.72 | 2 |
| ABBVIE INC. | $20.97 | 1 |
| Lilly USA, LLC | $19.70 | 1 |
| Astellas Pharma US Inc | $15.96 | 1 |
| Abbott Laboratories | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.95 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124810017 | CMS |
| ABBVIE INC. | $20.97 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369890 | CMS |
| Astellas Pharma US Inc | $15.96 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139297618 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.45 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105657384 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105484987 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.56 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105841123 | CMS |
| GlaxoSmithKline, LLC. | $22.23 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115884252 | CMS |
| GlaxoSmithKline, LLC. | $18.49 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116467802 | CMS |
| Lilly USA, LLC | $19.70 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387719 | CMS |
| Novo Nordisk Inc | $19.34 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097055241 | CMS |
| Novo Nordisk Inc | $20.89 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097460566 | CMS |
| Novo Nordisk Inc | $23.63 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096586779 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.